Literature DB >> 25485536

Epigenetic modulation of the muscarinic type 3 receptor in salivary epithelial cells.

Yong-Hwan Shin1, Meihong Jin1, Sung-Min Hwang1, Seul-Ki Choi1, Eun Namkoong1, Minkyoung Kim1, Moon-Yong Park1, Se-Young Choi1, Jong-Ho Lee2, Kyungpyo Park1.   

Abstract

Muscarinic receptors, particularly the type 3 subtype (M3R), have an important role in exocrine secretion. M3R normally function in HSG cells originated from human submandibular gland ducts, but not in A253 and SGT cells, derived from human submandibular carcinoma and salivary gland adenocarcinoma. However, the underlying mechanism of this suppression has remained elusive. In this study, we examined whether M3R function is suppressed by epigenetic modulation of the receptor. To this end, we investigated the mRNA transcript and protein levels of the M3R using reverse transcriptase-PCR, western blot, and confocal microscopy analyses. Global DNA methylation assays, methylation-specific PCR, and bisulfite sequencing were also performed to understand the epigenetic status of the M3R CpG island. We found that A253 cells expressed all subtypes of muscarinic receptors, except M3R, on the mRNA level. However, treatment of cells with 5-aza-2'-deoxycytidine (5-Aza-CdR), a DNA-demethylating agent, increased the expression levels of both M3R mRNA transcript and protein in proportion to the incubation period. 5-Aza-CdR completely restored the carbachol-induced calcium response, which was not observed in untreated A253 cells. In untreated A253 cells, all CG pairs from the 1st to 14th were methylated and 5-Aza-CdR treatment demethylated one of the methylated CG pairs. We also examined the methylation pattern of M3R CpG island in human cancer tissue. Interestingly, the result was very similar to those of A253 cells. All CG pairs in M3R CpG island were also methylated. Another salivary gland tumor cell line, SGT, also showed the similar methylation pattern, heavy methylation in M3R CpG island. It is concluded that CpG island in M3R is hypermethylated in cancer cell lines and human cancer. Our results further suggest that 5-Aza-CdR could potentially be used to restore the function of M3R, suppressed in some cancer cell types.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25485536     DOI: 10.1038/labinvest.2014.150

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  40 in total

1.  Characterization of Ca2+ mobilization in the human submandibular duct cell line A253.

Authors:  G H Zhang; R J Helmke; J R Martinez
Journal:  Proc Soc Exp Biol Med       Date:  1997-10

Review 2.  On the physiological relevance of muscarinic acetylcholine receptors in Alzheimer's disease.

Authors:  H J Koch; S Haas; T Jürgens
Journal:  Curr Med Chem       Date:  2005       Impact factor: 4.530

3.  Identification of silencing of nine genes in human gastric cancers.

Authors:  Atsushi Kaneda; Michio Kaminishi; Kazuyoshi Yanagihara; Takashi Sugimura; Toshikazu Ushijima
Journal:  Cancer Res       Date:  2002-11-15       Impact factor: 12.701

4.  Sphingosine-1-phosphate signaling in human submandibular cells.

Authors:  J Seo; N Y Koo; W Y Choi; J A Kang; J H Min; S H Jo; S J Lee; S B Oh; J S Kim; J H Lee; S Y Choi; K Park
Journal:  J Dent Res       Date:  2010-07-22       Impact factor: 6.116

5.  DNA demethylating agent decitabine increases AQP5 expression and restores salivary function.

Authors:  Y Yamamura; K Aota; T Yamanoi; K Kani; H Takano; Y Momota; K Motegi; M Azuma
Journal:  J Dent Res       Date:  2012-04-20       Impact factor: 6.116

6.  Expression of aquaporin-5 in and fluid secretion from immortalized human salivary gland ductal cells by treatment with 5-aza-2'-deoxycytidine: a possibility for improvement of xerostomia in patients with Sjögren's syndrome.

Authors:  Katsumi Motegi; Masayuki Azuma; Tetsuya Tamatani; Yuki Ashida; Mitsunobu Sato
Journal:  Lab Invest       Date:  2005-03       Impact factor: 5.662

Review 7.  Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development.

Authors:  Jürgen Wess; Richard M Eglen; Dinesh Gautam
Journal:  Nat Rev Drug Discov       Date:  2007-09       Impact factor: 84.694

8.  Epigenetic regulation of a novel tumor suppressor gene (hDAB2IP) in prostate cancer cell lines.

Authors:  Hong Chen; Shinichi Toyooka; Adi F Gazdar; Jer-Tsong Hsieh
Journal:  J Biol Chem       Date:  2002-11-21       Impact factor: 5.157

9.  Different muscarinc receptors are involved in the proliferation of murine mammary adenocarcinoma cell lines.

Authors:  Alejandro J Español; María E Sales
Journal:  Int J Mol Med       Date:  2004-02       Impact factor: 4.101

10.  Coordinated activation of candidate proto-oncogenes and cancer testes antigens via promoter demethylation in head and neck cancer and lung cancer.

Authors:  Ian M Smith; Chad A Glazer; Suhail K Mithani; Michael F Ochs; Wenyue Sun; Sheetal Bhan; Alexander Vostrov; Ziedulla Abdullaev; Victor Lobanenkov; Andrew Gray; Chunyan Liu; Steven S Chang; Kimberly L Ostrow; William H Westra; Shahnaz Begum; Mousumi Dhara; Joseph Califano
Journal:  PLoS One       Date:  2009-03-23       Impact factor: 3.240

View more
  2 in total

1.  Epigenetic alteration of the purinergic type 7 receptor in salivary epithelial cells.

Authors:  Yong-Hwan Shin; Minkyoung Kim; Nahyun Kim; Seul-Ki Choi; Eun Namkoong; Se-Young Choi; Jong-Ho Lee; Seunghee Cha; Kyungpyo Park
Journal:  Biochem Biophys Res Commun       Date:  2015-09-21       Impact factor: 3.575

2.  Epigenetic Modification of CFTR in Head and Neck Cancer.

Authors:  Yonghwan Shin; Minkyoung Kim; Jonghwa Won; Junchul Kim; Seog Bae Oh; Jong-Ho Lee; Kyungpyo Park
Journal:  J Clin Med       Date:  2020-03-09       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.